Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2007-01-01 / Thyroid 2007 Jan;17(1):53-8Advances in prostate cancer immunotherapies
/in International Publications, Prostate Cancer /von 2007-01-01 / Drugs Aging 2007;24(3):197-221Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines
/in International Publications, Malignant Melanoma /von 2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-6Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
/in Hypernephroma, International Publications /von 2007-01-01 / J. Immunother. 2007 Jan;30(1):116-22Cell technologies in immunotherapy of cancer
/in Hypernephroma, International Publications /von 2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-93Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile
/in HIV/AIDS, International Publications /von 2007-01-01 / Viral Immunol. 2007;20(1):160-9Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response
/in Colorectal Cancer, International Publications /von 2007-01-01 / Folia Histochem. Cytobiol. 2007;45(4):349-55Immunological role of dendritic cells in cervical cancer
/in Cervical Cancer, Dendritic Cells, International Publications /von 2007-01-01 / Adv. Exp. Med. Biol. 2007;601:155-62
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de